1. Home
  2. TACO vs NPCE Comparison

TACO vs NPCE Comparison

Compare TACO & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TACO
  • NPCE
  • Stock Information
  • Founded
  • TACO 2024
  • NPCE 1997
  • Country
  • TACO United States
  • NPCE United States
  • Employees
  • TACO N/A
  • NPCE N/A
  • Industry
  • TACO Blank Checks
  • NPCE Medical Specialities
  • Sector
  • TACO Finance
  • NPCE Health Care
  • Exchange
  • TACO Nasdaq
  • NPCE Nasdaq
  • Market Cap
  • TACO 389.8M
  • NPCE 342.7M
  • IPO Year
  • TACO 2025
  • NPCE 2021
  • Fundamental
  • Price
  • TACO $10.40
  • NPCE $10.92
  • Analyst Decision
  • TACO
  • NPCE Strong Buy
  • Analyst Count
  • TACO 0
  • NPCE 6
  • Target Price
  • TACO N/A
  • NPCE $16.67
  • AVG Volume (30 Days)
  • TACO 90.6K
  • NPCE 165.0K
  • Earning Date
  • TACO 01-01-0001
  • NPCE 11-11-2025
  • Dividend Yield
  • TACO N/A
  • NPCE N/A
  • EPS Growth
  • TACO N/A
  • NPCE N/A
  • EPS
  • TACO N/A
  • NPCE N/A
  • Revenue
  • TACO N/A
  • NPCE $88,570,000.00
  • Revenue This Year
  • TACO N/A
  • NPCE $22.13
  • Revenue Next Year
  • TACO N/A
  • NPCE $6.07
  • P/E Ratio
  • TACO N/A
  • NPCE N/A
  • Revenue Growth
  • TACO N/A
  • NPCE 23.32
  • 52 Week Low
  • TACO $10.20
  • NPCE $5.45
  • 52 Week High
  • TACO $11.32
  • NPCE $18.98
  • Technical
  • Relative Strength Index (RSI)
  • TACO N/A
  • NPCE 67.25
  • Support Level
  • TACO N/A
  • NPCE $9.76
  • Resistance Level
  • TACO N/A
  • NPCE $10.52
  • Average True Range (ATR)
  • TACO 0.00
  • NPCE 0.44
  • MACD
  • TACO 0.00
  • NPCE 0.04
  • Stochastic Oscillator
  • TACO 0.00
  • NPCE 85.52

About TACO Berto Acquisition Corp. Ordinary Shares

Berto Acquisition Corp is a blank check company.

About NPCE Neuropace Inc.

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.

Share on Social Networks: